Accretion Nutraveda Key Ratios
BSE: 544694
₹271.75
₹-19.75
(-6.78%)
As on 24-Sep-2026IST
Market cap
₹197 Cr
Revenue (TTM)
₹34 Cr
P/E Ratio
38.8
P/B Ratio
6.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 110.00 | 126.21 | -- |
| EBIT | -- | -- | 89.52 | 177.60 | -- |
| Net Profit | -- | -- | 102.66 | 162.38 | -- |
| EPS | -- | -- | 36.32 | 107.87 | -- |
| Book Value | -- | -- | 320.31 | 290.75 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| 20.29 | -- | 19.75 | 21.88 | 19.23 |
| Net Margin
| 15.49 | -- | 15.03 | 15.62 | 15.82 |
| Return on equity
| 77.04 | -- | 27.68 | 81.51 | 121.94 |
| Return on Capital
| 43.28 | -- | 30.19 | 57.66 | 42.00 |
| Return on Assets
| 23.75 | -- | 19.38 | 32.97 | 18.90 |
| Debt to Equity (x)
| -- | -- | 0.13 | 0.76 | 2.00 |
Profitability
ROCE
30.19
Higher than Peers by 16.16
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
30.19
|
57.66
|
42.00
|
21.40
|
--
|
|
Peer Median
|
14.03
|
16.46
|
15.49
|
17.37
|
--
|
ROE
27.68
Higher than Peers by 14.23
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
27.68
|
81.51
|
121.94
|
106.65
|
--
|
|
Peer Median
|
13.45
|
13.87
|
14.72
|
15.70
|
--
|
ROA
19.38
Higher than Peers by 11.44
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
19.38
|
32.97
|
18.90
|
6.91
|
--
|
|
Peer Median
|
7.94
|
8.04
|
7.19
|
9.43
|
--
|
EBIT Margin
19.75
Lower than Peers by 1.57
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
19.75
|
21.88
|
19.23
|
10.69
|
--
|
|
Peer Median
|
21.31
|
10.05
|
10.28
|
13.90
|
--
|
Net Margin
15.03
Higher than Peers by 3.15
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
15.03
|
15.62
|
15.82
|
9.14
|
--
|
|
Peer Median
|
11.88
|
9.11
|
6.78
|
10.91
|
--
|
Cash Profit Margin
15.86
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
15.86
|
17.01
|
21.65
|
20.39
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
110.00
Higher than Peers by 94.08
Year on year growth in net sales
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
110.00
|
219.70
|
72.41
|
--
|
--
|
|
Peer Median
|
15.92
|
7.17
|
10.56
|
12.63
|
--
|
EBIT Growth
89.52
Higher than Peers by 64.75
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
89.52
|
263.82
|
210.25
|
--
|
--
|
|
Peer Median
|
24.76
|
12.05
|
6.17
|
-2.90
|
--
|
Net Profit Growth
102.66
Higher than Peers by 78.41
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
102.66
|
204.28
|
192.91
|
--
|
--
|
|
Peer Median
|
24.25
|
22.15
|
27.97
|
-14.10
|
--
|
EPS Growth
36.32
Higher than Peers by 10.20
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
36.32
|
124.93
|
192.93
|
--
|
--
|
|
Peer Median
|
26.11
|
8.80
|
--
|
-3.68
|
--
|
Book Value Growth
524.85
--
Year on year growth in book value per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
524.85
|
365.66
|
312.35
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.13
Lower than Peers by 0.04
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
0.13
|
0.76
|
2.00
|
7.50
|
--
|
|
Peer Median
|
0.17
|
0.03
|
0.05
|
0.14
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
--
|
0.28
|
1.38
|
1.66
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
11.98
Higher than Peers by 9.75
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
11.98
|
2.87
|
1.07
|
1.07
|
--
|
|
Peer Median
|
2.23
|
2.20
|
1.93
|
1.82
|
--
|
Quick Ratio
8.42
Higher than Peers by 6.60
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
8.42
|
1.36
|
0.29
|
0.53
|
--
|
|
Peer Median
|
1.82
|
1.72
|
1.59
|
1.30
|
--
|
Interest Coverage
12.57
Higher than Peers by 1.26
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
12.57
|
9.89
|
4.82
|
2.50
|
--
|
|
Peer Median
|
11.31
|
12.28
|
12.45
|
16.98
|
--
|
Operating Efficiency
Debtors to sales
24.14
Lower than Peers by 6.68
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
24.14
|
20.41
|
4.99
|
27.56
|
--
|
|
Peer Median
|
30.82
|
26.23
|
23.97
|
24.57
|
--
|
Asset Turnover
1.28
Higher than Peers by 0.56
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
1.28
|
2.11
|
1.15
|
0.72
|
--
|
|
Peer Median
|
0.72
|
0.74
|
0.88
|
0.82
|
--
|
Receivable days
61.80
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
61.80
|
40.10
|
38.28
|
100.61
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
73.78
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
73.78
|
79.49
|
133.99
|
162.84
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
12.43
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
12.43
|
30.77
|
161.86
|
354.92
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
123.15
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
123.15
|
88.82
|
10.41
|
-91.47
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
29.71
Lower than Peers by 27.43
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
29.71
|
--
|
--
|
--
|
--
|
|
Peer Median
|
57.14
|
39.17
|
40.74
|
25.97
|
--
|
Price / Book Value
4.77
Lower than Peers by 0.18
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
4.77
|
--
|
--
|
--
|
--
|
|
Peer Median
|
4.95
|
3.61
|
3.87
|
2.79
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.11
|
0.19
|
0.20
|
0.65
|
--
|
EV/EBITDA
20.70
Lower than Peers by 26.63
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
20.70
|
1.16
|
1.71
|
2.85
|
--
|
|
Peer Median
|
47.33
|
28.79
|
25.41
|
15.07
|
--
|
Market Cap
151
Lower than Peers by 6,160
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Accretion Nutraveda
|
151
|
--
|
--
|
--
|
--
|
|
Peer Median
|
6,311
|
3,944
|
2,959
|
3,742
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
